baber/WOPTO huggingface dataset:
Patent MY-181540-A (MY)
Title: Transdermal composition containing donepezil as active ingredient
Inventor: CHOI YOUNG KWEON
IPC: A61K31/445
Filed: 2015-12-18
Abstract: The present invention relates to a transdermal composition for dementia treatment containing donepezil as an active ingredient. The transdermal composition according to the present invention contains highly concentrated donepezil in a hydrophobic matrix, can continuously release the drug for a long time by having excellent long-term adhesion to the skin, and further exhibits consistently effective therapeutic effects over a long period of time by having a significantly improved skin penetration rate in comparison with conventional donepezil patches.  Figure 1
Patent MY-180978-A (MY)
Title: Packaging authentication
Inventor: ROGER P SMITH
Filed: 2016-05-05
Abstract: An authentication system (10, 110) including a package (12, 112) that includes a container (18, 118), an ultraviolet (UV) protector (22, 122b) carried by the container, and a UV light responder (24, 124) carried by the container so that at least a portion thereof is protected by the protector from premature exposure to UV light. After removal of the UV light protector, the UV light responder is responsive to a predetermined schedule of UV light exposure so as to change in visual appearance within a predetermined time. The predetermined schedule may include a predetermined wavelength of UV light applied in a predetermined amount and over a predetermined application time. A related apparatus and authentication method are also disclosed.    The most illustrative drawing: Fig. 1
Patent MY-186400-A (MY)
Title: Eukaryotic cell with increased production of fermentation product
Inventor: PAPAPETRIDIS IOANNIS
IPC: C12N9/12
Filed: 2016-10-03
Abstract: The present invention relates to a eukaryotic cell that is genetically modified comprising one or more heterologous gene encoding: a)	D-glucose-6-phosphate dehydrogenase and/or b)	6-phosphogluconate dehydrogenase; and/or c)	glucose dehydrogenase, gluconolactonase and gluconate kinase,  wherein a), b) and glucose dehydrogenase in c) are NAD+ dependent.
Patent MY-191180-A (MY)
Title: Coal ash granulated material, manufacturing method for the same, and bottom improvement method
Inventor: NISHINA HARUKI
IPC: B01J2/00
Filed: 2016-03-07
Abstract: The present invention provides a coal ash granulated material that has a high strength and water absorption coefficient. The coal ash granulated material is formed by a mixture of: a granulated material that is formed as granules and contains coal ash and a cement hydrate that binds the coal ash; a second coal ash; and a cement hydrate that binds the second coal ash and the granulated material. The coal ash granulated material has a larger particle diameter than the granulated material included therein. This coal ash granulated material is provided on the bottom of a body of water, and improves the bottom.  Fig. 1
Patent MY-186581-A (MY)
Title: Technology for efficient activation of nkt cells
Inventor: TANIGUCHI MASARU
Filed: 2017-04-14
Abstract: The present invention relates to a method for producing en NKT cell ligand-pulsed human CD14 positive cell that activates NKT cells and strongly induces proliferation, IFN- ? production, and/or cytotoxic activity of NKT cells. More specifically, the method is characterized in that the isolated CD14 positive cell is cultured in a medium containing an NKT cell ligand and GM-CSF and substantially free of IL-4. In addition, the present invention relates to a method for producing an NKT cell ligand-pulsed human CD14 positive cell line and, specifically, the method is characterized in that the isolated CD14 positive cell is cultured in a medium containing an NKT cell ligand and substantially free of GM-CSF and IL-4. The present invention also relates to a cell preparation containing an NKT cell ligand-pulsed human CD14 positive cell or an NKT cell ligand- pulsed human CD14 positive cell line and pharmaceutical use thereof.
Patent MY-193101-A (MY)
Title: Imprinted substrates
Inventor: BOWEN M SHANE
IPC: G03F7/038
Filed: 2017-09-11
Abstract: Imprinted substrates are often used to produce miniaturized devices for use in electrical, optic and biochemical applications. Imprinting techniques, such as nanoimprinting lithography, may leave residues in the surface of substrates that affect bonding and decrease the quality of the produced devices. An imprinted substrate with residue-free region, or regions with a reduced amount of residue for improved bonding quality is introduced. Methods (40; 60; 210) to produce imprinted substrates without residues from the imprinting process are also introduced. Methods (40; 60; 210) include physical exclusion methods, selective etching methods and energy application methods (40; 60; 210). These methods (40; 60; 210) may produce residue-free regions in the surface of the substrate that can be used to produce higher strength bonding. (Fig.4)
Patent MY-195639-A (MY)
Title: Anti-Counterfeit Container
Inventor: FISCHBACH ELMAR MARTIN
IPC: B65D51/20
Filed: 2017-12-19
Abstract: The invention provides a container for infant formula food with anti-counterfeit measures. In order to prevent counterfeiting, the container comprises a cover for closing the container. An outer scannable code is provided on the container so as to be scannable from the outside. Inside the container, a gas-tight membrane seal for sealing a food content of the container prior to use is provided. On the gas-tight membrane seal, an inner scannable code is provided so as to be only scannable after opening the container.   (Fig. 1)
Patent MY-188851-A (MY)
Title: Battery replacement device unlocking apparatus, battery replacement device and battery box quick battery replacement system
Inventor: HUANG CHUNHUA
Filed: 2018-12-29
Abstract: A battery replacement device unlocking apparatus, a battery replacement device and a battery box quick battery replacement system. In the battery replacement device unlocking apparatus, a driving element (1) is connected to a transmission mechanism (2) and drives same to move, and the transmission mechanism (2) is connected to an unlocking bar (3) and drives same to expand and retract. In the battery box quick battery replacement system, a battery box (7) comprises a locking tongue (71) and a linked unlocking button, the unlocking button (72) being provided correspondingly to the unlocking bar (3); the unlocking bar (3) expands to press the unlocking button, so as to drive the locking tongue (71) to disengage from the locking part to unlock. The battery replacement device unlocking apparatus, the battery replacement device, and the battery box quick battery replacement system have high unlocking accuracy and high battery replacement efficiency.
Patent MY-191983-A (MY)
Title: Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolyl-glycyl-l-tyrosinate and methods for preparing the same
Inventor: KANG SANG UK
IPC: A61K38/07
Filed: 2020-08-03
Abstract: The present invention relates to a pharmaceutical formulation having excellent bioavailability and stability, comprising sodium palmitoyl-L-prolyl-L-prolyl-glycyl-L-tyrosinate (Compound I) as an active ingredient. The pharmaceutical formulation according to the present invention can be usefully used as a dosage form for treating inflammatory bowel disease and the like since Compound I, an active ingredient, is not decomposed in the stomach and released in the intestine.
Patent MY-193352-A (MY)
Title: A surgical dressing product having a multi-dimensional flexible hydrophilic structure-linkage composite
Inventor: LIU CHIH CHUNG
IPC: A61L15/60
Filed: 2018-08-13
Abstract: This invention provides a surgical dressing product (1) having a designed multi- dimensional flexible hydrophilic structure-linkage composite (10), comprising: a cushion layer (20), and a multiple of hydrophilic microsphere (30), wherein said multi-dimensional flexible hydrophilic structure-linkage composite (10) comprising a hydrophilic multi-dimensional flexible structure-linkage membrane (13), and a multiple of structure-linkage holes (15) positioned into said hydrophilic multi- dimensional flexible structure-linkage membrane (13), and the sizes of structure- linkage holes (15) changed with the degree of compelling force, resulting in a multi- dimensional flexible structure-linkage relationship and a consolidating structure.
Patent MY-194548-A (MY)
Title: A formwork for precast concrete panel
Inventor: MOHD ZIKRI BIN MD ZAINI
IPC: E04G13/04
Filed: 2019-04-04
Abstract: The present invention relates to a formwork (10) for precast concrete panel used in building construction. The formwork (10) comprises a base (11) and an elongated channel (12) having two upright walls connected to the base (11). Herein, the elongated channel (12) having an opening at the top portion and the cross-section of the elongated channel (12) is U-shaped. The formwork (10) is preferably made of a combination of cement, fiber glass and polystyrene.  Figure 1
Patent SG-10201808837R-A (SG)
Title: Anti-egfr antibodies and antibody drug conjugates
Inventor: REILLY EDWARD
Filed: 2015-03-20
Abstract: ANTI-EGFR ANTIBODIES AND ANTIBODY DRUG CONJUGATES The invention relates to anti-epidermal growth factor (EGFR) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs. [Figure 4]
Patent SG-10201907044X-A (SG)
Title: Methods and apparatuses for pushing a message
Inventor: WANG JUNXIANG
Filed: 2016-02-03
Abstract: METHODS AND APPARATUSES FOR PUSHING A MESSAGE Apparatuses and methods are disclosed for pushing a message. An exemplary method may include extracting, when the message to be pushed is detected, user information and application information in the message. The method may also include acquiring link information corresponding to the user information and the application information. The method may further include determining registered devices of a user account and registered applications on each registered device according to the user information, the application information, and the link information. The method may further include adding, when a plurality of registered applications on a registered device exist, identification information about the plurality of registered applications to the message corresponding to the registered device. The identification information and message contents contained in the message may be extracted and the message contents may be respectively sent to each registered application corresponding to the identification information by the registered device after receiving the message. Fig. 2
Patent SG-11201408770R-A (SG)
Title: Compounds and therapeutic uses thereof
Inventor: WILLARDSEN J ADAM
IPC: C07D213/69
Filed: 2013-06-27
Abstract: (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 3 January 2014 (03.01.2014) WIPOIPCT (10) International Publication Number WO 2014/004884 A1 (51) International Patent Classification: C07D 213/69 (2006.01) (21) International Application Number: (22) International Filing Date: (25) Filing Language: (26) Publication Language: PCT/US2013/048274 27 June 2013 (27.06.2013) English English (30) Priority Data: 61/665,297 27 June 2012 (27.06.2012) (71) Applicant: ALZHEIMER'S INSTITUTE OF AMER ICA, INC. [US/US]; 7837 Parallel Parkway, Kansas City. Kansas 66112-2493 (US). (72) Inventors: WILLARDSEN, J. Adam; 14413 Bridgefield Dr., Draper, Utah 84020 (US). LOCKMAN, Jeffrey W.; 26 Dunbar Drive, Princeton Junction, New Jersey 08550 (US). MURPHY, Brett R.; 60770 Salt Creek Rd„ Coil- bran, Colorado 81624 (US). JUDD, Weston R.; 1284 South Cave Hollow Lane, Farmington, Utah 84025 (US). YAGER, Kraig M.; 633 Lincoln Place, Murray, Utah 84107 (US). (74) Agent: ECHOLS, Kelly A.; STOEL RIVES LLP, 201 So. Main Street, Suite 1100, One Utah Center, Salt Lake City, Utah 84111 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available)'. AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. Ug (84) Designated States (unless otherwise indicated, for every kind of regional protection available)'. ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3)) — before the expiration of the time limit for amending the claims and to be republished in the event of receipt of amendments (Rule 48.2(h)) (54) Title: COMPOUNDS AND THERAPEUTIC USES THEREOF o > •o (D £ •t 00 00 •t o o Vehicle Parent Cmpd. A (3mpk, BID) Parent Cmpd. A (4mpk, BID) Parent Cmpd. A (5mpk, BID) Parent Cmpd. A (7mpk, BID) Parent Cmpd. A (9mpk, BID) 10 15 time (days) Figure O CJ o & (57) Abstract: The invention relates to compounds, pharmaceutical compositions and methods useful for treating cancer, systemic or chronic inflammation, rheumatoid arthritis, diabetes, obesity, T-cell mediated autoimmune disease, ischemia, and other complica­ tions associated with these diseases and disorders.
Patent SG-11201805159V-A (SG)
Title: Method for reducing corrosive ions in aromatic compound extraction solvent
Inventor: KARAKI KEISUKE
IPC: C23F11/14
Filed: 2016-10-31
Abstract: METHOD FOR REDUCING CORROSIVE IONS IN AROMATIC COMPOUND EXTRACTION SOLVENT In order to suppress corrosion of an extractor caused by corrosive ions contained in an aromatic compound extraction solvent of a circulation system, a method for reducing corrosive ions in an aromatic compound extraction solvent is provided, by which the corrosive ions in the aromatic compound extraction solvent are conveniently and efficiently reduced. A method for reducing corrosive ions in an aromatic compound extraction solvent in a circulation system where the aromatic compound extraction solvent circulates, the corrosive ions being at least one kind selected from the group consisting of chloride ions, sulfate ions, and sulfite ions, the method comprising: a step of forming a non-volatile salt by adding a corrosive ion scavenger to react the corrosive ions with the corrosive ion scavenger, and a step of removing the salt resulting from concentrating the solvent comprising the salt. [No suitable figure]
Patent SG-11201811635V-A (SG)
Title: Intraocular lens injector
Inventor: WATANABE YOSHITAKA
IPC: A61F2/16
Filed: 2017-06-28
Abstract: There is provided an intraocular lens injector for injecting an intraocular lens into an eye, including: an injector main body 5; an injection tube 7 attached to a tip part of the injector main body 5 and having a nozzle portion 7b; and an attachment member 16 having a protruding surface disposed in a state of protruding to outside from an outer circumferential surface of the nozzle portion 7b, wherein the attachment member 16 has an engaging portion 16b engaged with a sleeve portion 16a and is configured to be movable with respect to the injection tubed 7. (Fig. 1)
Patent SG-11201903882V-A (SG)
Title: Il-2 variants for the treatment of autoimmune diseases
Inventor: GREVE JEFFREY
IPC: A61K38/00
Filed: 2017-11-08
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property 111111101111011101 HIM 0110100111111111111111111111111111111111111111110111111 Organization 0 International Bureau (10) International Publication Number (43) International Publication Date ......0\" WO 2018/089420 Al 17 May 2018 (17.05.2018) WIPO I PCT (51) International Patent Classification: C07K 14/55 (2006.01) A61K 38/00 (2006.01) Published: C12N 5/0783 (2010.01) — with international search report (Art 21(3)) — before the expiration of the time limit for amending the (21) International Application Number: claims and to be republished in the event of receipt of PCT/US2017/060534 amendments (Rule 48.2(h)) (22) International Filing Date: — with sequence listing part of description (Rule 5.2(a)) 08 November 2017 (08.11.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/419,118 08 November 2016 (08.11.2016) US (71) Applicant: DELINIA, INC. [US/US]; 5980 Horton Street, Suite 470, Emeryville, CA 94608 (US). (72) Inventor: GREVE, Jeffrey; 1066 Park Hills Road, Berke- ley, CA 94708 (US). (74) Agent: KRIKELIS, Basil S. et al.; McCarter & English, LLP, Renaissance Centre, 405 N. Market Street, 8th Floor, Wilmington, DE 19801 (US). Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (81) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). (84) 1-1 © ei iv pp ot (54) Title: IL-2 VARIANTS FOR THE TREATMENT OF AUTOIMMUNE DISEASES ---- (57) : This disclosure provides for a method for treating a condition by administering to a subject in need thereof a therapeu- 0 GC , 1 tically-effective amount of a compound that comprises an IL-2 receptor-binding moiety. The methods described in the present disclo- 0 sure provide enhanced pharmacokinetic profiles. The disclosure also provides methods for treating autoimmune disease comprising N administering a therapeutically-effective amount of a fusion protein comprising an IL-2 variant protein. C
Patent HU-204476-B (HU)
Inventor: RECSEI JOZSEF
IPC: C02F1/52
Filed: 1987-01-12
Abstract: A találmány tárgya eljárás és berendezés szennyezett vizek tisztítására. A találmány szerinti eljárás azzal jellemezhető, hogy flokkulálószerrel, célszerűen szervetlen fémsó, flokkulálószerrel elegyített szennyezett vizet felülről lefelé áramoltatva egy koagulátorba viszik, és gáz mikrobuborékkal telített vízzel elkevert polielektrolittal elegyítik, ahol a gáz mikrobuborékokkal telített víz: polielektrolit egymás közötti térfogataránya 1:1 2,5:1 közötti, majd a flokkulált részecskéket tartalmazó elegyből egy felülúsztatóban 1 m3 tisztítandó elegyre számítva 0,1-0,3 m3 mennyiségű gáz mikro- HU 204 476 A A leírás terjedelme: 6 oldal (ezen belül 1 lap ábra)
Patent IS-2407-B (IS)
Inventor: HOF ROBERT PATRICK
IPC: C07B61/00
Filed: 2004-06-22
Abstract: The invention relates to a process for the conversion of group X in a 2-(6-substituted)-1,3-dioxane-4yl) acetic acid derivative according to formula 2 into a group OY in the presence of a phase transfer catalyst and an oxylating agent, by using as a phase transfer catalyst a quarternary phosphonium ion and by using as an oxylating agent an OY<-> ion. X stands for a halogen and R<1>, R<2> and R<3> are each independently a C1-4 alkylgroup or R<1> and R<2> together with the C-atom to which they are bound form a 5- or 6-membered cycloalkyl; Y stands for R<A>-CO- or for R<B>-SO2- with R<A>, R<B> are chosen from the group of alkyl or aryl with 1-12 C-atoms. <IMAGE>
Patent YU-44252-B (YU)
Title: Process for preparation of glucose and fructose
Inventor: WEIDENBACH G
IPC: C13K11/00
Filed: 1985-01-09
Abstract: Disclosed is a process for the preparation of a solution containing glucose and fructose (isoglucose) by the conversion of a glucose-containing solution on a catalyst having glucose isomerase activity and produced on the basis of a SiO2 carrier. The productivity of the catalyst may be significantly increased by the addition of SiO2 to the glucose solution, and the catalyst according to the present invention is not damaged by temporary process shutdowns.
Patent YU-48749-B (YU)
Title: 4-benzoylizoxazole derivatives, production procedure, herbicidal preparations containing mentioned derivatives and method for the weed growth control
Inventor: ALFRED CAIN PAUL
IPC: C07D261/08
Filed: 1993-02-04
Abstract: 4-Benzoyl isoxazole derivatives of general formula (I): <CHEM>     wherein     R represents a hydrogen atom or a group -CO2R<5>; R<1> represents methyl, isopropyl, cyclopropyl or 1-methylcyclopropyl;     R<2> represents -S(O)nR<5><1>; R<3> represents a chlorine, bromine or fluorine atom, a straight- or branched- chain alkyl, alkoxy, haloalkyl or haloalkoxy group, an alkenyl group or a methyl or ethyl ester group; R<4> represents a chlorine, bromine or fluorine atom; an alkyl, alkoxy haloalkyl, haloalkoxy, -S(O)pR<5><3> or cyano group;     R<5> represents an alkyl or haloalkyl group;     R<5><1> and R<5><3> independently represent an alkyl group, and     n and p independently represent zero, one or two, and their use as herbicides is described.
Patent AT-404850-B (AT)
Title: Permanent way with rails and intermediate plates
Inventor: SALZMANN HEINRICH ING
IPC: E01B9/68
Filed: 1993-02-18
Granted: 1999-03-25
Abstract: Permanent way with rails 2 for rail-bound vehicles, the rails of a track being releasably connected to supporting plates 1 by fastening means, for example by screws 10 and clamping clips 11, and there being provided between the rail feet 4 and the supporting plate 1 elastomerically deformable intermediate plates 5, 7, which have surface regions which extend essentially parallel to the longitudinal direction of the rails and have different elastomeric deformability when the rails are subjected to compressive loading, the elastomeric deformability of the intermediate plates 5, 7 in curves of the permanent way of the two rails of a track being designed to decrease transversely to the longitudinal direction of the rails from the inner side of the curve 1 to the outer side of the curve A, so that when the rails 2 of a track are subjected to loading a canting movement of the latter is prevented. <IMAGE>
Patent AT-387154-B (AT)
Title: Safety ski binding
IPC: A63C9/08
Filed: 1987-02-13
Granted: 1988-12-12
Abstract: This safety ski binding has a baseplate 3 which is to be fastened to the upper side of the ski and bears a vertical pivot pin 4, on which pivot pin 4 a footplate 8 is pivotably mounted, which bears, at its rear end, a heel-holder 2 with a sole-holder 6 acted on by a catch spring 25 and, at its front end, a toepiece. The footplate 8 is pressed in the direction of its central position by the catch spring 25. In order, in such a ski binding, to guarantee an additional release of the ski boot by a relative movement of the heel-holder 2 in relation to the footplate 8 in the case of pure horizontal loading as well, the heel- holder 2 has, as is known per se, a bearing block 16 which is pivotable with its base 16a about a vertical spindle 61, the vertical spindle 61 for the bearing block 16 is fastened to the footplate 8, and the bearing block 16 is assigned an additional roller 19 which is pressed against a control cam 3a arranged on the baseplate 3 by an additional spring 21. <IMAGE>